Analysis of Simvastatin (anti-cholesterol drug) gel in bone formation.
Phase 2
Completed
- Conditions
- Health Condition 1: K011- Impacted teethHealth Condition 2: K011- Impacted teeth
- Registration Number
- CTRI/2022/09/046022
- Lead Sponsor
- Dr Monika Gupta
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 40
Inclusion Criteria
Surgical site should be free of infection.
Patient requiring extraction bilaterally of impacted mandibular third molars.
The site should be where primary wound closure can be achieved.
Exclusion Criteria
Patient having connective tissue/bleeding disorders.
Patient who have undergone radiation/chemotherapy to head and neck region.
Patients allergic to drug simvastatin.
Patient having uncontrolled diseases of systemic nature.
Patients with fibro-osseous diseases of bone.
Any pathology associated with apical region of mandibular third molar.
Patients on immuno-supressants and/or on anticoagulants.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method